Gynuity Health Projects start a clinical trial to obtain data on feasibility of telemedicine medical abortion

This pilot study is designed to obtain data on the safety, acceptability, and feasibility of providing abortion by direct-to-patient telemedicine and mail.

The non-profit reproductive health organization has initiated clinical trials in USA and plans to enroll 2500 participants.

This clinical trial started on October 1, 2020 and its completion is expected in 2022.

The medically ineligible for procedure is exclusion criteria.

The list of locations:

  • Planned Parenthood of the Rocky Mountains, Denver, Colorado, United States, 80207
  • Carafem, Washington, District of Columbia, United States, 20815
  • Carafem, Atlanta, Georgia, United States, 30309
  • The University of Hawaii Women's Options Centers, Honolulu, Hawaii, United States, 96826
  • Carafem, Skokie, Illinois, United States, 60076
  • Emma Goldman Clinic, Iowa City, Iowa, United States, 52245
  • Maine Family Planning, Augusta, Maine, United States, 04332
  • Carafem, Chevy Chase, Maryland, United States, 20815
  • Planned Parenthood Minnesota, North Dakota, South Dakota, Saint Paul, Minnesota, United States, 55114
  • Planned Parenthood of Montana, Billings, Montana, United States, 59102
  • Planned Parenthood of the Rocky Mountains, Albuquerque, New Mexico, United States, 80207
  • Maine Family Planning, New York, New York, United States, 04332
  • Planned Parenthood Columbia Willamette, Portland, Oregon, United States, 97212
  • Planned Parenthood Columbia Willamette, Vancouver, Washington, United States, 97212

The page dedicated to this clinical trial can be found here:

Clinical Research News

Upcoming Clinical Trials